Antibody-Drug Conjugates (ADC) Technology Research and Global Markets Report 2024-2025 & 2029 with Profiles of Leading Players - F. Hoffmann-La Roche., Daiichi Sankyo, Pfizer, and Gilead Sciences
November 04, 2024 07:00 ET
|
Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Antibody-Drug Conjugates: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global sales of ADCs on...
Antibody Drug Conjugates Industry Report (2024-2032) Featuring Profiles the Top 13 Players - ADC Therapeutics, Astellas Pharma, AstraZeneca, Celldex Therapeutics, Roche & More
October 09, 2024 10:13 ET
|
Research and Markets
Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Report by Component, Target, Application, End-user, and Region 2024-2032" report has been added to ...
Antibody Drug Conjugates Market Size Potential to Reach USD 39 Billion by 2032 By IMIR Market Research Pvt. Ltd.
October 07, 2024 09:38 ET
|
IMIR Market Research Pvt. Ltd.
Gondia, India, Oct. 07, 2024 (GLOBE NEWSWIRE) -- In 2023, the Antibody Drug Conjugates market size was valued at USD 5,475.84 Million and is expected to reach USD 39,153.21 Million at the CAGR of...
Cancer Engineered Antibody Therapeutics Market Analysis 2024: Technology Advances and Increasing Interest from Tier I Pharmaceuticals Driving Growth of Engineered Antibodies
August 15, 2024 07:35 ET
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Engineered Antibody Therapeutics for Cancer" report has been added to ResearchAndMarkets.com's offering.This study analyzes the emergence of...
Middle East & Africa Antibody Drug Conjugates Market Forecast to 2030 - Growing Strategic Partnerships to Develop Antibody Drug Conjugates and Escalating Pipeline of ADCs
June 26, 2024 04:23 ET
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Middle East & Africa Antibody Drug Conjugates Market Forecast to 2030 - Regional Analysis - By Technology, Application, and Distribution Channel"...